Literature DB >> 23271757

Aspartylglucosaminuria: unusual neonatal presentation in Qatari twins with a novel aspartylglucosaminidase gene mutation and 3 new cases in a Turkish family.

Thomas Opladen1, Friedrich Ebinger, Johannes Zschocke, Devjani Sengupta, Tawfeg Ben-Omran, Noora Shahbeck, Ute Moog, Christine Fischer, Friederike Bürger, Dorothea Haas, Peter Ruef, Inga Harting, Hilal Al-Rifai, Georg F Hoffmann.   

Abstract

Aspartylglucosaminuria is a rare autosomal recessive lysosomal storage disorder leading early to a progressive intellectual disability. Monozygous Qatari twins presented with an unusual perinatal manifestation characterized by severe muscular hypotonia, scarce spontaneous movements, multiple contractures, and respiratory insufficiency. Biochemical investigations suggested aspartylglucosaminuria, and a novel homozygous mutation c.439T>C (p.S147P) was found in the aspartylglucosaminidase gene. However, it cannot be excluded that the unusual neonatal presentation is due to an additional autosomal recessive disease in this multiply consanguineous family. The classical aspartylglucosaminuria phenotype (progressive speech delay, psychomotor retardation, and behavioral abnormalities) was observed in 3 Turkish siblings. Although aspartylglucosaminuria was suspected early, the definite diagnosis was not confirmed until the age of 18 years. A novel homozygous mutation c.346C>T (p.R116W) was found. These 5 cases emphasize that aspartylglucosaminuria is panethnic and may possibly present with prenatal manifestation. Screening for aspartylglucosaminuria should be done in all patients with unexplained psychomotor retardation.

Entities:  

Keywords:  AGA gene mutation; aspartylglucosaminidase; aspartylglucosaminuria; neonatal presentation

Mesh:

Substances:

Year:  2012        PMID: 23271757     DOI: 10.1177/0883073812469049

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  6 in total

1.  Structural basis of a point mutation that causes the genetic disease aspartylglucosaminuria.

Authors:  Lufei Sui; Damodharan Lakshminarasimhan; Suchita Pande; Hwai-Chen Guo
Journal:  Structure       Date:  2014-11-13       Impact factor: 5.006

2.  The T99K variant of glycosylasparaginase shows a new structural mechanism of the genetic disease aspartylglucosaminuria.

Authors:  Suchita Pande; Hwai-Chen Guo
Journal:  Protein Sci       Date:  2019-04-09       Impact factor: 6.725

3.  Brain MRI findings in two Turkish pediatric patients with aspartylglucosaminuria.

Authors:  Ayşe Kartal; Kürşad Aydın
Journal:  Neuroradiol J       Date:  2016-08-22

4.  Biochemical and structural insights into an allelic variant causing the lysosomal storage disorder - aspartylglucosaminuria.

Authors:  Suchita Pande; William Bizilj; Hwai-Chen Guo
Journal:  FEBS Lett       Date:  2018-07-23       Impact factor: 4.124

5.  Identification of Small Molecule Compounds for Pharmacological Chaperone Therapy of Aspartylglucosaminuria.

Authors:  Antje Banning; Christina Gülec; Juha Rouvinen; Steven J Gray; Ritva Tikkanen
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

6.  Functional Analysis of the Ser149/Thr149 Variants of Human Aspartylglucosaminidase and Optimization of the Coding Sequence for Protein Production.

Authors:  Antje Banning; Jan F König; Steven J Gray; Ritva Tikkanen
Journal:  Int J Mol Sci       Date:  2017-03-26       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.